Pfizer Reaping $11 Billion Gain from Trump’s Tax Overhaul

HeadlineJan 31, 2018
H3 pfizer

In financial news, the pharmaceutical giant Pfizer says it’s reaping a staggering $11 billion gain as a result of President Trump’s tax overhaul, which massively benefited corporations and the richest Americans. President Trump and Republicans claimed the tax plan would help the middle class, but a recent Reuters poll shows only 2 percent of surveyed workers say they’ve received any benefit from Trump’s tax overhaul.

Topics:
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop